{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T23:02:08Z","timestamp":1781478128390,"version":"3.54.1"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Idiopathic central precocious puberty (CPP) precipitates epiphyseal fusion of growth plates in long bones, leading to reduced adult stature. Gonadotropin-releasing hormone analogues (GnRHa) are the treatment of choice for idiopathic CPP, but their benefit on height gain is unclear. We aimed to elucidate the effects of GnRHa treatment on adult height in girls with idiopathic CPP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>This prospective observational descriptive study analyzed data of girls with idiopathic CPP diagnosed at 55 centers in Spain between January 1, 1998 and December 31, 2012 included in the Spanish Society for Pediatric Endocrinology\u2019s national registry.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We included girls with idiopathic CPP (thelarche &amp;lt; 8 years, positive LHRH stimulation test, bone age &amp;gt; 1 year older than chronological age, and normal brain imaging) treated with triptorelin (3.75 mg monthly, adjusted according to LHRH test results and clinical findings). We assessed weight, height, BMI, and secondary sexual characteristics every 6 months and bone age every 12 months until adult height (AH) was attained. The primary outcome was the difference between AH and target height (TH).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 465 girls (18.90% adopted) were included; we analyzed data recorded at treatment end in 358 girls and at AH in 216. Mean difference between AH and TH was -1.5 (95%CI: -2.56\u2212 -0.45) cm and between AH and PAH 2,57 (95%CI:-3.56\u2212 -1.58) cm.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>GnRHa treatment helps preserve genetic growth potential in girls with idiopathic CPP.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2024.1498726","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T09:31:36Z","timestamp":1733477496000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Adult height in girls with idiopathic central precocious puberty treated with triptorelin"],"prefix":"10.3389","volume":"15","author":[{"given":"Raquel","family":"Corripio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro","family":"Soriano-Guill\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco-Javier","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Castro-Feijo\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ar\u00e1nzazu","family":"Escribano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Sol-Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Espino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaia","family":"Vela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9-Ignacio","family":"Labarta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The Spanish PUBERE Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Argente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MED.0b013e3283207937","article-title":"Endocrinology of female puberty","volume":"16","author":"DiVall","year":"2009","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe1306743","article-title":"Releasing the brake on puberty","volume":"368","author":"Hughes","year":"2013","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1025","article-title":"Central precocious puberty in children living in Spain: incidence, prevalence, and influence of adoption and immigration","volume":"95","author":"Soriano-Guillen","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1210\/er.2002-0019","article-title":"The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration","volume":"24","author":"Parent","year":"2003","journal-title":"Endocr Rev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.mce.2009.12.017","article-title":"Metabolic signals in human puberty: effects of over and undernutrition","volume":"324","author":"Martos-Moreno","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1159\/000336325","article-title":"Recent secular trends in pubertal timing: implications for evaluation and diagnosis of precocious puberty","volume":"77","author":"S\u00f8rensen","year":"2012","journal-title":"Horm Res Paediatr"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2826.2007.01598.x","article-title":"The genetic basis for the timing of human puberty","volume":"19","author":"Banerjee","year":"2007","journal-title":"J Neuroendocrinol"},{"key":"B8","doi-asserted-by":"crossref","DOI":"10.1002\/9780470987117","article-title":"Normal and abnormal puberty","volume-title":"Brook's Clinical Pediatric Endocrinology","author":"Charles Brook","year":"2005"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/nature13545","article-title":"Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche","volume":"514","author":"Perry","year":"2014","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-1813F","article-title":"Link between body fat and the timing of puberty","author":"Kaplowitz","year":"2008","journal-title":"Pediatrics"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2010.09.039","article-title":"The transcriptional control of female puberty","volume":"1364","author":"Ojeda","year":"2010","journal-title":"Brain Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1590\/2359-3997000000144","article-title":"Central precocious puberty: revisiting the diagnosis and therapeutic management","volume":"60","author":"Brito","year":"2016","journal-title":"Arch Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1136\/adc.44.235.291","article-title":"Variations in pattern of pubertal changes in girls","volume":"44","author":"Marshall","year":"1969","journal-title":"Arch Dis Child"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2019.5881","article-title":"Worldwide secular trends in age at pubertal onset assessed by breast development among girls: a systematic review and meta-analysis","volume":"174","author":"Eckert-Lind","year":"2020","journal-title":"JAMA Pediatr"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp0800459","article-title":"Clinical practice","volume":"358","author":"Carel","year":"2008","journal-title":"Precocious puberty. N Engl J Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1159\/000178041","article-title":"Peripheral precocious puberty: causes and current management","author":"Eugster","year":"2009","journal-title":"Horm Res"},{"key":"B17","first-page":"1","article-title":"Etiology of precocious puberty, 10 years study in Endocrine Reserch Centre (Firouzgar), Tehran","volume":"10","author":"Rohani","year":"2012","journal-title":"Iran J Reprod Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmh012","article-title":"Precocious puberty and statural growth","volume":"10","author":"Carel","year":"2004","journal-title":"Hum Reprod Update"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1159\/000071228","article-title":"The effects of manipulation of puberty on growth","volume":"60","author":"Lee","year":"2003","journal-title":"Horm Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000260","article-title":"Gonadotropin releasing hormone agonist treatment to increase final stature in children with precocious puberty: a meta-analysis","volume":"93","author":"Li","year":"2014","journal-title":"Med (Baltimore)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.10.7915","article-title":"Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience","volume":"86","author":"Klein","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0321","article-title":"Growth pattern and final height after cessation of gonadotropin-suppressive therapy in girls with central sexual precocity","volume":"92","author":"Lazar","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14410","article-title":"Long-term efficacy and safety of gonadotropin-releasing hormone analog treatment in children with idiopathic central precocious puberty: A systematic review and meta-analysis","volume":"94","author":"Luo","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1136\/adc.75.4.292","article-title":"Final height in central precocious puberty after long term treatment with a slow release GnRH agonist","volume":"75","author":"Oostdijk","year":"1996","journal-title":"Arch Dis Child"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14214","article-title":"Adult height after gonadotropin-releasing hormone agonist treatment in girls with early puberty: A meta-analysis","volume":"93","author":"Park","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4274\/jcrpe.2017.S004","article-title":"A critical appraisal of the effect of gonadotropin-releasing hormon analog treatment on adult height of girls with central precocious puberty","volume":"9","author":"Bereket","year":"2017","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-1783","article-title":"Consensus statement on the use of gonadotropin-releasing hormone analogs in children","volume":"123","author":"Carel","year":"2009","journal-title":"Pediatrics"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-4471","article-title":"36-month treatment experience of two doses of leuprolide acetate 3-month depot for children with central precocious puberty","volume":"99","author":"Lee","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2013.05.033","article-title":"A single histrelin implant is effective for 2 years for treatment of central precocious puberty","volume":"163","author":"Lewis","year":"2013","journal-title":"J Pediatr"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1159\/000439330","article-title":"Experience with the histrelin implant in pediatric patients","volume":"30","author":"Eugster","year":"2016","journal-title":"Endocr Dev"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3031","article-title":"Long-term continuous suppression with once-yearly histrelin subcutaneous implants for the treatment of central precocious puberty: a final report of a phase 3 multicenter trial","volume":"100","author":"Silverman","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B32","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1517\/13543784.15.5.495","article-title":"Treatment of central precocious puberty","volume":"15","author":"Tuvemo","year":"2006","journal-title":"Expert Opin Investig Drugs"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1159\/000448552","article-title":"Changes in body mass index in girls with idiopathic central precocious puberty under gonadotropin-releasing hormone analogue therapy: the Spanish Registry","volume":"86","author":"Corripio","year":"2016","journal-title":"Horm Res Paediatr"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3748","article-title":"Treated and untreated women with idiopathic precocious puberty: BMI evolution, metabolic outcome, and general health between third and fifth decades","volume":"100","author":"Lazar","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B35","volume-title":"Curvas y tablas de crecimiento","author":"Hern\u00e1ndez","year":"1988"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(52)80205-7","article-title":"Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards","volume":"40","author":"Bayley","year":"1952","journal-title":"J Pediatr"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1542\/peds.68.2.251","article-title":"Height predictions in girls with idiopathic precocious puberty by the Bayley-Pinneau method","volume":"68","author":"Kirkland","year":"1981","journal-title":"Pediatrics"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(22)00339-4","article-title":"Molecular basis of normal and pathological puberty: from basic mechanisms to clinical implications","volume":"11","author":"Argente","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/jne.12979","article-title":"Precocious sexual maturation: Unravelling the mechanisms of pubertal onset through clinical observations","volume":"34","author":"Soriano-Guill\u00e9n","year":"2022","journal-title":"J Neuroendocrinol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0590","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: Long-term outcomes of the treatment of central precocious puberty","volume":"174","author":"Guaraldi","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1515\/JPEM.2006.19.11.1327","article-title":"Weight evolution in girls treated for idiopathic central precocious puberty with GnRH analogues","volume":"19","author":"Aguiar","year":"2006","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1159\/000197862","article-title":"Body mass index and body composition in adolescents treated with gonadotropin-releasing hormone analogue triptorelin depot for central precocious puberty: data at near final height","volume":"89","author":"Chiocca","year":"2009","journal-title":"Neuroendocrinology"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1498726\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T09:31:40Z","timestamp":1733477500000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1498726\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":42,"alternative-id":["10.3389\/fendo.2024.1498726"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2024.1498726","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]},"article-number":"1498726"}}